FDA Approved: BEXAROTENE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals NY LLC's original-application generic of Bexarotene for cutaneous T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Bexarotene (Bexarotene)

Snippet

ORIG AP for BEXAROTENE (BEXAROTENE)